Cell Culture Market Status and Prospects 2023 to 2033 | By Danaher, Corning, Merck KgaA, PromoCell, Sartorius

The global Cell Culture Market size is anticipated to be valued at US$ 25.4 billion in 2022 and US$ 29.0 billion in 2023. Furthermore, with rising demand for biopharmaceuticals such as vaccines and stem cells, as well as increased R&D activities, the global Cell Culture market is predicted to rise at an astounding 11.8% CAGR between 2023 and 2033, reaching a valuation of around US$ 88.6 billion by 2033.

As per FMI, the key market drivers during the forecast period are:

• Acceleration of research and development operations to aid in biopharmaceutical mass production
• Demand for sophisticated Cell Culture-based products is increasing.
• Broad applicability in pharmaceutical firms, research institutes, and food development
• Chronic diseases that necessitate medicinal advancements
• Consumer demand for monoclonal antibodies (mAbs) is increasing.

Request a report sample to gain compressive insights@ https://www.futuremarketinsights.com/reports/sample/rep-gb-14318

Cell Culture Application in Pharma & Health is Key to Market Growth

Currently, innovation is propelling market expansion. Demand for improved variations of Cell Culture goods is increasing as many end-user segments engage extensively in Cell Culture research and development. Similarly, there is an increased demand for innovative therapies such as biosimilars that improve market prospects.

All of these variables have combined to carve out a unique application of Cell Culture in the pharmaceutical and healthcare sectors. This is mostly due to an increase in cancer, renal illness, diabetes, and cardiovascular disease. With increased consumer demand for better treatment alternatives, Cell Culture can open up lucrative opportunities for the pharmaceutical and healthcare industries.

Key Players Need to Find a Way Out of Market Bottlenecks to Aid Growth

Product development necessitates extensive cell biology research. However, this leads to the necessity for significant expenditure. Manufacturers must invest in high-quality equipment and other inputs to make high-end products that meet stringent regulatory criteria. This limits the availability of Cell Culture resources to smaller businesses. The same is true for research centres with restricted resources. Manufacturers must devote time and technical skills in cell harvesting even further down the industrial chain. If significant businesses can overcome these technical stumbling blocks, the industry could grow even more in the next years.

Get a Discount on the Report@ https://www.futuremarketinsights.com/request-discount/rep-gb-14318

Key Takeaways from the Report:

• Between 2017 and 2022, the market grew at a 13.5% CAGR, reaching a valuation of US$ 25.4 billion by 2022.
• The US market is expected to grow at an 11.6% CAGR during the forecast period, reaching a valuation of US$ 31.4 billion by 2033.
• The United Kingdom market is predicted to grow at a CAGR of 10.9% between 2023 and 2033, reaching a valuation of US$ 3.7 billion by 2033.
• During the forecast period, the consumables segment is expected to grow at a 11.4% CAGR.
• During the projection period, the biopharmaceutical production segment is expected to grow at an 11.1% CAGR.

Key Market Developments:

• In January 2022, Cytiva (Danaher Corporation) announced its collaboration with Nucleus Biologics. This can be an important step towards developing custom culture media for cell as well as gene therapies.
• In February 2022, KromaTiD enhanced its services by venturing into cell and blood culture isolation, and processing, coupled with quality control services

Key Players:

• Danaher Corporation
• Thermo Fisher Scientific
• Becton
• Dickinson and Company
• Corning Incorporated
• Merck KgaA
• PromoCell GmbH
• Sartorius AG

We Offer tailor-made Solutions to fit Your Requirements, Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-14318

Key Segments

By Product:

• Consumables
  • Sera
  • Media
  • Reagents
  • Vessels
  • Accessories
• Equipment
  • Supporting Equipment
  • Bioreactors
  • Storage Equipment

By Application:

• Biopharmaceutical Production
  • Monoclonal antibodies
  • Vaccines production
  • Other therapeutic proteins
• Diagnostics
  • Drug Screening & Development
    • Tissue Engineering & Regenerative Medicine
  • Cell and gene therapy
• Others

By End User:

• Pharmaceutical & Biotechnology Companies
• Hospitals & Diagnostic Laboratories
• Research & Academic Institutes
• Others

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn | Twitter | Blogs